# 癌症：英文版

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/s4306555428/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1000-467X |
| ISSNs | 1000-467X,1944-446X,2523-3548 |
| OpenAlex ID | https://openalex.org/S4306555428 |

## Journal papers

- [The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma](https://scholariq.org/papers/the-chinese-society-of-clinical-oncology-csco-clinical-guidelines-for-the/)
- [The International Agency for Research on Cancer (IARC) evaluation of the carcinogenicity of outdoor air pollution: focus on China](https://scholariq.org/papers/the-international-agency-for-research-on-cancer-iarc-evaluation-of-the/)
- [Essential roles of exosome and circRNA_101093 on ferroptosis desensitization in lung adenocarcinoma](https://scholariq.org/papers/essential-roles-of-exosome-and-circrna-101093-on-ferroptosis-desensitization-in/)
- [N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA](https://scholariq.org/papers/n-acetyltransferase-10-promotes-colon-cancer-progression-by-inhibiting/)
- [Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art](https://scholariq.org/papers/neoadjuvant-immunotherapy-for-non-small-cell-lung-cancer-state-of-the-art/)
- [Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy](https://scholariq.org/papers/tumor-organoids-synergistic-applications-current-challenges-and-future-prospects/)
- [Functions and clinical significance of mechanical tumor microenvironment: cancer cell sensing, mechanobiology and metastasis](https://scholariq.org/papers/functions-and-clinical-significance-of-mechanical-tumor-microenvironment-cancer/)
- [Roles of low-density lipoprotein receptor-related protein 1 in tumors](https://scholariq.org/papers/roles-of-low-density-lipoprotein-receptor-related-protein-1-in-tumors/)
- [Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)](https://scholariq.org/papers/sintilimab-versus-docetaxel-as-second-line-treatment-in-advanced-or-metastatic/)
- [A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy](https://scholariq.org/papers/a-prospective-analysis-of-factors-that-influence-weight-loss-in-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.